This disrupted interplay, first described by Brismar’s group and confirmed in our cohort, suggests a profound dysregulation of the IGF system in T1DM that may contribute to metabolic and vascular complications [21]. This evidence concerns the gene IGF1 and type 1 diabetes mellitus.